← Leaderboards
Sally Arai
Rush University Medical Center
$655,043
Attributed
$655,043
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $132.3K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$655,043 · 1
By mechanism
K23$655,043 · 1
Top collaborators
No co-investigators on record.
Most similar at Rush University Medical Center
Same institution · by research overlap
- Ronald Hoffman$16,556,136
- Azra Raza$4,021,821
- Marina Emborg$10,094,272
- Timothy J. Collier$11,066,916
- Kent W Christopherson$398,840
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IGraft Versus Host DiseaseClinical ResearchCell LineNatural Killer CellsBlood /Lymphatic NeoplasmTissue /Cell CultureImmunotherapyStem Cell TransplantationHuman Therapy EvaluationHuman SubjectPatient Oriented ResearchClinical Trials, Phase IiClinical Trials, Phase ICellsClinical Trials DesignFutureClinical TrialsAllogenicEthics Committees, ResearchEngraftmentEnd PointDoseCareer
Grant awards (6)
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$132,300
K23 · FY2007 · AI · contact PI
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$132,300
K23 · FY2006 · AI · contact PI
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$132,300
K23 · FY2005 · AI
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$122,196
K23 · FY2004 · AI
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$10,127
K23 · FY2004 · AI
GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy$125,820
K23 · FY2003 · AI